Stockreport

Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

NovoCure Limited - Ordinary Shares  (NVCR) 
Last novocure limited - ordinary shares earnings: 4/30 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: novocure.com/investor-relations
PDF Full year 2025 net revenues of $655 million and fourth quarter net revenues of $174 millionOptune Pax® approved by the U.S. FDA for the treatment of locally advanced pan [Read more]